etoposide has been researched along with Venous Thromboembolism in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batra, S; Karanth, SS; Sharma, D; Vaid, AK | 1 |
Aparicio, J; Ayala de la Peña, F; Carmona-Bayonas, A; Castellano, D; Cerezuela, P; Duran, I; Fernandez, A; Fernandez, S; García Del Muro, X; Germà-Lluch, JR; Gonzalez-Billalabeitia, E; Guma, J; Hervas, D; Luengo, MI; Luis Aguilar, J; Manneh, R; Margeli, M; Maroto, P; Mellado, B; Rivera, S; Ros, S; Saenz, A; Sanchez-Muñoz, A; Sastre, J; Sobrevilla, N; Valverde, C | 1 |
Chekerov, R; Fotopoulou, C; Karavas, A; Lichtenegger, W; Sehouli, J; Trappe, R | 1 |
1 trial(s) available for etoposide and Venous Thromboembolism
Article | Year |
---|---|
Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Germany; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Topotecan; Venous Thromboembolism | 2009 |
2 other study(ies) available for etoposide and Venous Thromboembolism
Article | Year |
---|---|
Mediastinal germ cell tumour causing superior vena cava tumour thrombosis.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chest Pain; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Heparin, Low-Molecular-Weight; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Treatment Outcome; Vena Cava, Superior; Venous Thromboembolism | 2015 |
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Proportional Hazards Models; Registries; Survival Rate; Venous Thromboembolism; Young Adult | 2017 |